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After a typhoon in September 2009, an outbreak of 
leptospirosis occurred in Metro Manila, the Philippines; 471 
patients were hospitalized and 51 (10.8%) died. A hospital-
based investigation found risk factors associated with fatal 
infection to be older age, hemoptysis, anuria, jaundice, and 
delayed treatment with antimicrobial drugs.
Leptospirosis is highly endemic to the Philippines. Outbreaks usually occur during the typhoon season 
(July–October) (1–3). On September 26, 2009, a typhoon 
caused serious fl ooding in Metro Manila (4). Starting 
in the fi rst week of October, the number of patients with 
suspected signs and symptoms of leptospirosis increased 
sharply. Until mid-November, 2,299 patients, including 
178 who died (case-fatality ratio [CFR] 8%), in 15 hospitals 
in Metro Manila were reported to the Department of Health 
(4,5). For this outbreak, we conducted a hospital-based 
investigation to describe the characteristics of hospitalized 
patients, investigate risk factors for death, and identify the 
causative Leptospira species and serogroups.
The Study
We conducted our investigation at San Lazaro Hospital, 
a national 500-bed referral infectious disease center for 
Metro Manila and neighboring provinces, which mostly 
serves economically disadvantaged persons. On October 
11, 2009, this hospital initiated prospective surveillance 
and retrospective data collection. The study ended on 
October 31, when cases had decreased to baseline level (<1 
case/d). The list of patients was obtained from the inpatient 
database with International Classifi cation of Diseases, 10th 
revision, coding. Vital sign information and laboratory 
fi ndings at admission were collected from medical charts.
Eligible were all hospitalized patients who had 
1) fever plus at least 2 other signs and symptoms of 
leptospirosis (headache, myalgia, eye pain, nausea, 
vomiting, abdominal pain, diarrhea, conjunctival 
suffusion, jaundice, tea-colored urine, oliguria, anuria, or 
unusual bleeding) (6); 2) history of wading in fl oodwater; 
and 3) symptoms that started September 26–October 
31. We evaluated prognostic factors and the effect of 
therapeutic factors by using univariate and multivariate 
Poisson regression analyses with robust SEs (7).
A total of 486 cases met clinical criteria for 
leptospirosis; 15 were excluded because of insuffi cient 
data. Patients were predominantly young and male (Table 
1). The most common clinical features were conjunctival 
suffusion and myalgia, followed by abdominal pain and 
oliguria. Among 471 patients, 51 died (CFR 10.8%); 12 
(2.6%) were discharged before improvement; and 7 (1.5%) 
were transferred to other hospitals, mainly for dialysis. 
Primary causes of death were pulmonary hemorrhage (18 
[35%]) and acute respiratory distress syndrome/severe 
respiratory failure (12 [24%]), followed by acute renal 
failure (10 [20%]) and multiple organ failure/disseminated 
intravascular coagulation (8 [16%]). Mean time ± SD from 
illness onset to death was 7.7 ± 5 days; 36 (71%) died 
within 2 days of admission.
Univariate analysis showed the following to be 
associated with death: older age, jaundice, anuria, and 
hemoptysis (Table 1). Of the initial laboratory fi ndings, 
neutrophilia, thrombocytopenia, increased blood urea 
nitrogen, and increased creatinine levels were associated 
with death. Most patients received antimicrobial drugs 
(mainly penicillin G) as fi rst-line treatment. Delayed 
initiation of treatment increased risk for death (Table 2). 
No patient received prophylactic antimicrobial therapy. 
Administration of rapid volume replacement therapy and 
diuretics was associated with death but probably refl ected 
severe renal disease. Only 1 patient received peritoneal 
dialysis and 1 received mechanical ventilation.
During the outbreak, 2 kinds of rapid diagnostic tests 
for leptospirosis—Leptospira Serology Kit (Bio-Rad, 
Marnes-la-Coquette, France) and PanBio IgM ELISA 
(Panbio Diagnostics, Brisbane, Queensland, Australia)—
were available in the hospital, although the number of kits 
was limited. Plasma collection for additional laboratory 
confi rmation started October 11. Samples were initially 
stored at –4°C in the hospital laboratory and then frozen at 
–40°C in the National Reference Laboratory, STD/AIDS 
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Cooperative Central Laboratory, San Lazaro Hospital. 
In June 2010, microscopic agglutination test (MAT) and 
PCR were performed in the National Institute of Infectious 
Diseases, Tokyo, Japan, as described (8,9). A case was 
defi ned as laboratory confi rmed if 1) specifi c antibodies 
were detected with titer >400 or at least a 4-fold increase 
in reciprocal MAT titer between paired samples, 2) PCR 
for Leptospira fl aB gene was positive for at least 1 blood 
sample, or 3) rapid diagnostic test result (either test) was 
positive for at least 1 blood sample.
A total of 134 plasma samples were collected from 93 
patients. From 25 patients, 2–4 samples were collected; 
mean time from fi rst to last collection was 6.1 (range 
1–18) days. Among the 93 patients, 15 had a single MAT 
titer >400 and 4 showed a 4-fold increase in the MAT 
titer in paired samples. Most antibodies were against L. 
borgpetersenii serovar Tarassovi, followed by serovars 
Poi and Sejroe and L. interrogans serovars Losbanos and 
Manilae. PCR produced positive results for 4 patients, 2 of 
whom had a negative MAT titer. PCR-detected Leptospira 
strains were phylogenetically characterized by the fl aB 
sequence (8,9); 3 were identical to those of isolates from 
rats in Metro Manila, but 1 was distinct (Figure).
Rapid-test results were available for 85 case-patients; 
48 of 78 samples were positive by Leptospira Serology Kit 
and 5 of 7 were positive by ELISA. Of 27 cases tested by 
MAT and Leptospira Serology Kit, 6 were positive by both 
tests. One sample was negative by MAT and ELISA. Taken 
together, 149 (32%) of all cases underwent any diagnostic 
testing for leptospirosis, and results for 67 (45%) of these 
were laboratory confi rmed. Clinical and laboratory fi ndings 
of laboratory-confi rmed and suspected cases, respectively, 
were almost identical except for the presence of jaundice 
(61.2% vs. 45.5%; p = 0.018), convulsions (4.5% vs. 0%; 
p = 0.003), and death (3% vs. 12.1%; p = 0.03). No plasma 
sample test results have been validated; thus, deduced 
incidence should be considered with caution. To explore 
the possibility of hantavirus co-infection contributing to 
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Table 1. Characteristics of 471 leptospirosis patients, San Lazaro Hospital, Manila, the Philippines, 2009* 
Characteristic
No. (%) patients total, 
n = 471 
No. (%) patients 
who died, n = 51 
Univariate analysis 
Risk ratio 95% CI 
Sex     
 M 424 (90) 45 (88.2) Reference 
 F 47 (10) 6 (11.8) 1.2 0.54–2.67 
Age >30 y† 235 (49.9) 37 (72.6) 2.65 1.47–4.78 
Low BMI, <20, n = 398 129 (32.4) 16 (35.6) 1.15 0.65– 2.04 
Clinical features, n = 471     
 Headache 246 (52.2) 19 (37.3) 0.54 0.32–0.93 
 Myalgia 361 (76.7) 36 (70.6) 0.73 0.42–1.29 
 Cough 83 (17.6) 3 (5.6) 0.29 0.09–0.92 
 Malaise 208 (44.2) 23 (45.1) 1.04 0.62–1.75 
 Vomiting 272 (57.8) 22 (43.1) 0.56 0.33–0.94 
 Abdominal pain 288 (61.2) 28 (54.9) 0.77 0.46–1.3 
 Diarrhea 192 (40.8) 24 (47.1) 1.29 0.77–2.17 
 Conjunctival suffusion 368 (78.1) 41 (80.4) 1.15 0.6–2.21 
 Jaundice 225 (47.8) 38 (74.5) 3.2 1.74–5.84 
 Tea-colored urine 156 (33.1) 17 (33.3) 1.01 0.58–1.75 
 Oliguria 286 (60.7) 27 (52.9) 0.73 0.43–1.22 
 Anuria 26 (5.5) 10 (19.6) 4.17 2.37–7.36 
 Hemoptysis 15 (3.2) 7 (13.7) 4.84 2.63–8.9 
 Skin hemorrhage 2 (0.4) 0 NA 
 Convulsion 3 (0.6) 1 (2) 3.12 0.62–15.82 
 Dizziness 43 (9.1) 1 (2) 0.2 0.03–1.41 
Vital status at admission    
 Hypotension, <100 mm Hg, n = 455 177 (38.9) 14 (28.6) 0.63 0.35–1.13 
 Tachycardia, >100 beats/min, n = 461 84 (18.2) 14 (27.5) 1.7 0.96–3.0 
 Tachypnea, >20 breaths/min, n = 460 253 (55) 34 (66.7) 1.64 0.94–2.84 
Initial laboratory findings     
 Neutrophilia, >12 x 109 cells/L, n = 430 171 (39.8) 18 (58.1) 2.1 1.05–4.17 
 Thrombocytopenia, <50 x 103 cells/L, n = 426 50 (11.7) 10 (33.3) 3.76 1.87–7.57 
 AST >100 IU/L, n = 220 44 (20) 2 (28.6) 1.6 0.32–8.0 
 ALT >100 IU/L, n = 220 34 (15.5) 2 (28.6) 2.2 0.44–10.9 
 BUN >80 mg/dL, n = 385 185 (48.1) 12 (75) 3.24 1.06–9.89 
 Cr >3.0 mg/dL, n = 413 183 (44.3) 13 (72.2) 3.27 1.19–9.01 
*BMI, body mass index; NA, not applicable; AST, aspartate aminotransferase; ALT, alanine transaminase; BUN, blood urea nitrogen; Cr, creatinine. 
†Mean ± SD 31.3 ± 13.1 for total patients, 39.5 ± 13.6 for patients who died; risk ratio (95% CI) 1.04 (1.02–1.06). 
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the high CFRs, we screened samples for antibodies against 
hantavirus (10), but all were negative.
Conclusions
Risk factors for fatal leptospirosis were jaundice, 
anuria, and hemoptysis at admission. These are typical signs 
of the severe form of leptospirosis called Weil disease (11), 
confi rming earlier work (12,13). Hemoptysis with high 
CFR (7 [47%] of 15) may have represented leptospirosis-
associated severe pulmonary hemorrhagic syndrome (14). 
Some clinical features, including cough, seemed to be 
associated with lower risk for death, but minor symptoms in 
dying patients might have been overlooked. High leukocyte 
counts, blood urea nitrogen and creatinine levels, and lower 
platelet counts were also associated with death.
Deaths could be reduced if these indicators are detected 
and appropriate management introduced early. Laboratory 
data such as potassium level might also be helpful, but 
these tests are often not available for all suspected cases 
in resource-poor settings, especially during outbreaks. 
The trend of most patients being male is compatible with 
previous reports and thought to refl ect higher exposure to 
contaminated water (6,12–14).
Although all patients received antimicrobial therapy, 
a considerable proportion died of acute respiratory distress 
syndrome and acute renal failure within only 2 days of 
admission, indicating that most patients sought care too 
late. The World Health Organization recommends starting 
antimicrobial therapy before the fi fth day of disease onset 
(6), but for half of the case-patients reported here, it was 
started after the fi fth day. Our results support the benefi ts 
of early initiation of antimicrobial therapy.
Renal failure was clearly a cause of death, but only 
1 patient received peritoneal dialysis and another 7 were 
transferred to other hospitals for hemodialysis after only 
3.4 days of hospitalization. This lack or delay of dialysis 
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Table 2. Effects of therapeutic approaches on death from leptospirosis, San Lazaro Hospital, Manila, the Philippines, 2009 
Therapeutic factor 
Total cases, 
n = 471* 
Fatal cases, 
n = 51* 
Univariate analysis Multivariate analysis 
Risk ratio 95% CI Risk ratio 95% CI 
Days from onset to first antimicrobial drug therapy, 
n = 466  
4.9 ± 2.6  5.6 ± 2.8 1.09 1.01–1.18  1.09† 1.00–1.17 
 <7 351 (75.3) 31 (63.3) Reference  Reference 
 >7 115 (24.7) 18 (36.7) 1.77 1.03–3.05  1.76† 1.03–3.01 
First antimicrobial agent used, n = 469        
 Penicillin G 434 (92.5) 47 (94) Reference  Reference 
 Ceftriaxone 10 (2.1) 2 (4) 0.79 0.26–2.42  0.62‡ 0.16–2.38 
 Doxycycline 9 (1.9) 0 (0) 
 Others 16 (3.4) 1 (2) 
Days from onset to admission† 5.1 ± 2.6 5.7 ± 3.2 1.08 1.0–1.16  1.08† 1.0–1.16 
Rapid volume replacement therapy        
 Performed 334 (70.9) 46 (90.2) 3.77 1.53–9.3  2.63§ 0.6–11.4 
 Not performed 137 (29.1) 5 (9.8) Reference  Reference 
Diuretics        
 Used 356 (75.6) 46 (90.2) 2.97 1.21–7.31  1.15§ 0.31–4.23 
 Not used 115 (24.4) 5 (9.8) Reference  Reference 
*Values are no. (%) or mean ± SD. 
†Adjusted for age group (<30 or >30 y). 
‡Adjusted for age group and duration from symptom onset to antimicrobial therapy initiation. 
§Adjusted for age group and creatinine level. 
Figure. Phylogenetic tree based on the Leptospira fl aB gene 
sequence. The sequences obtained in this study are indicated 
in boldface and have been deposited in DDBJ/GenBank/EMBL 
(accession numbers indicated). The sequences of rat isolates 
are derived from a previous study (9). Sequence alignments 
were conducted by using MEGA4 software and ClustalW (www.
megasoftware.net), and phylogenetic distances were calculated by 
using MEGA4 software and the neighbor-joining method. All 4 PCR 
products belong to L. interrogans; 2 are closely related to serovar 
Losbanos, 1 to serovar Manilae, and 1 is not associated with strains 
or serovars included in our analysis. Microscopic agglutination test 
results indicate infecting serogroups. L. borgpetersenii serovar 
Tarassovi had the highest titer in patients 307 and 486, but this 
fi nding can be explained by a cross-reaction. Scale bar indicates 
nucleotide substitutions per site.
might have affected outcomes. San Lazaro Hospital is not 
suffi ciently equipped for intensive care. Expanded access 
to peritoneal dialysis might reduce deaths from severe 
leptospirosis complicated by acute renal failure.
Leptospirosis is typically seen in resource-poor 
settings, where costly medical equipment such as dialyzers 
and ventilators are rarely accessible. For leptospirosis 
outbreak control and CFR reduction in leptospirosis-
endemic regions, continuous case and environmental 
monitoring and early introduction of appropriate treatment 
for suspected cases are warranted.
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